Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Diagnostic solutions748.89M37.86%
Sample technologies642.03M32.46%
Polymerase Chain Reaction (PCR) / Nucleic acid amplification300.47M15.19%
Genomics / Next-Generation Sequencing (NGS)233.61M11.81%
Other53.22M2.69%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States942.01M47.62%
Europe, Middle East and Africa627.59M31.73%
Asia Pacific, Japan and Rest of World298.15M15.07%
Other Americas89.56M4.53%
Netherlands20.9M1.06%